CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Marcus Gail Boxer Director | Sale | −116 | $218.82 | $25K | 6,183 |
| 2026-06-05 | Marcus Gail Boxer Director | Option exercise · Stock Option (right to buy) | −11,000 | 11,000 | ||
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −832 | $212.42 | $177K | 149,035 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,503 | $213.44 | $534K | 146,532 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,300 | $214.83 | $279K | 145,232 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −5,499 | $216.13 | $1.2M | 139,733 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,351 | $217.04 | $510K | 137,382 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,742 | $218.28 | $380K | 135,640 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,758 | $219.08 | $604K | 132,882 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,400 | $220.19 | $528K | 130,482 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,006 | $222.25 | $446K | 128,476 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −6,500 | $223.34 | $1.5M | 121,976 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,443 | $223.91 | $323K | 120,533 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,630 | $224.99 | $367K | 118,903 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −6,751 | $226.15 | $1.5M | 112,152 |
| 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,409 | $226.97 | $774K | 108,743 |
| 2026-06-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,802 | $217.52 | $392K | 138,841 |
| 2026-06-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −413 | $218.84 | $90K | 138,428 |
| 2026-06-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −213 | $219.34 | $47K | 138,215 |
| 2026-06-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −572 | $220.67 | $126K | 137,643 |
Page 17 of 39 · 767 trades